3-(IMIDAZOLYL)-2-ALKOXYPROPANOIC ACIDS AS TAFIA INHIBITORS - Patent 1467731

(19)

(11)

EP 1 467 731 A1

(12)

(43)	Date of publication:
	20.10.2004 Bulletin 2004/43

(21)	Application number: 03700059.3

(22)	Date of filing: 10.01.2003

(51)	International Patent Classification (IPC)⁷: A61K 31/4172, A61K 31/4174, A61K 31/4178, A61P 7/02, C07D 233/54, C07D 403/12

(86)	International application number:
	PCT/IB2003/000060

(87)	International publication number:
	WO 2003/061652 (31.07.2003 Gazette 2003/31)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
	Designated Extension States:
	AL LT LV MK RO

(30)

Priority:

22.01.2002 GB 0201389
29.01.2002 GB 0202027

(71)	Applicants:
	Pfizer Limited Sandwich,Kent CT13 9NJ (GB) GB PFIZER INC. New York, N.Y. 10017 (US)

(72)	Inventors:
	ALLERTON, Charlotte, M.,Pfizer Global Rch. & Dev. Sandwich,Kent CT13 9NJ (GB) BULL, David, J.,Pfizer Global Rch. and Dev. Sandwich,Kent CT13 9NJ (GB) BUNNAGE, Mark, E.,Pfizer Global Rch. and Dev. Sandwich,Kent CT13 9NJ (GB) MAGUIRE, Robert, J.,Pfizer Global Rch. and Dev. Sandwich,Kent CT13 9NJ (GB) STEELE, John,UK Patent Department Sandwich,Kent CT13 9NJ (GB)

(74)	Representative: Wood, David John
	Pfizer LimitedEuropean Patents Department,Ramsgate Road, Sandwich,Kent CT13 9NJ Sandwich,Kent CT13 9NJ (GB)

(54)	3-(IMIDAZOLYL)-2-ALKOXYPROPANOIC ACIDS AS TAFIA INHIBITORS